The PI3K/AKT/mTOR signalling pathway contributes to the development of cancers by regulating HIF-1a activation; blocking the PI3K/AKT pathway inhibits HIF-1a expression and promotes its degradation [139,140]. The gene discussed is AKT1; the disease is cancer.